Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

UFS academic joins an elite league of achievers
2010-04-14

Prof. Dingie van Rensburg, Director of the Centre for Health Systems Research  Development at the University of the Free State
Prof. Dingie van Rensburg
Prof. Dingie van Rensburg, Director of the Centre for Health Systems Research & Development at the University of the Free State (UFS), has joined an elite list of a only few distinguished individuals who have been awarded honorary doctorates by the University of Antwerp (UA) in Belgium.

He is only the third South African to be honoured in this way by the UA, following in the footsteps of Constitutional Court Judge Albie Sachs (2000) and former State President, Nelson Mandela (2004).

He is the first social scientist from South Africa to receive this honorary doctorate from the UA – the highest academic distinction of that university. The university has previously only awarded three honorary doctorates to social scientists: Prof. Raymond Boudon, sociologist at the University of Paris-Sorbonne (1995); Prof. Robert Putman, political scientist at Harvard University (2000); and Prof. John Nash (of A Beautiful Mind fame), mathematician and economist at Massachusetts Institute of Technology (MIT) and Princeton.

The award ceremony will take place on 29 April 2010 in Antwerp.

Prof. Van Rensburg has authored, co-authored and was editor of many books/volumes, chapters in books, monographs, research reports and articles in scientific journals. He has also presented and co-presented at numerous national and international conferences; and supervised a significant number of master’s, doctoral and post-doctoral students.

In his 17 years as director of the Centre he has initiated, managed and led approximately 50 research and development projects, several of them large and long-term projects, and many of an inter-institutional and multidisciplinary nature.

In 2002 he became an NRF-rated researcher and in 2007 his rating as an established researcher was renewed. In the past two decades he received several research grants simultaneously from both the National Research Foundation and the Medical Research Foundation of South Africa, mostly for projects on Tuberculosis, HIV/Aids and antiretroviral treatment.

Prof Van Rensburg holds membership of both the Suid-Afrikaanse Akademie vir Wetenskap en Kuns and the Academy for Science of South Africa; he also served for varying periods on the Councils of both these academies. He was also a member of various health bodies of the Free State Province and the National Science and Technology Forum.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
14 April 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept